| View |
|
DR-XY13333
|
Cetirizine Dihydrochloride
|
Virlix
|
10mg
|
Tablet
|
-
|
Repacker: Aesica Pharmaceuticals S.r.l.
|
Italy
|
-
|
21 February 2020
|
17 November 2024
|
| View |
|
DR-XY13358
|
Ondansetron (As Hydrocloride Dihydrate)
|
Zofran
|
2 mg/mL
|
Solution For Injection (I.M./I.V.)
|
-
|
GlaxoSmithKline Manufacturing S.p.A.
|
Italy
|
-
|
13 August 2020
|
21 July 2025
|
| View |
|
DR-XY13365
|
5% Dextrose in 0.9% Sodium Chloride
|
None
|
Each 100 mL contains 5 g Dextrose Monohydrate & 900 mg Sodium Chloride
|
Solution for I.V. Infusion
|
-
|
EURO-MED LABORATORIES PHIL., INC.
|
Philippines
|
Automatic Renewal
|
08 March 2022
|
25 June 2027
|
| View |
|
DR-XY13366
|
10% Dextrose In Water Solution For Iv Infusion
|
None
|
Each 100 mL contains 10 g Dextrose Monohydrate
|
Solution For Iv Infusion
|
Parenteral
|
EURO-MED LABORATORIES PHIL., INC.
|
Philippines
|
Automatic Renewal
|
28 March 2022
|
01 August 2027
|
| View |
|
DR-XY13367
|
5% Dextrose in 0.3% Sodium Chloride
|
None
|
Each 100 mL contains 5 g Dextrose Monohydrate & 300 mg Sodium Chloride
|
Solution for I.V Infusion.
|
-
|
EURO-MED LABORATORIES PHIL., INC.
|
Philippines
|
Automatic Renewal
|
14 March 2022
|
25 June 2027
|
| View |
|
DR-XY13371
|
Ondansetron (As Hydrochloride Dihydrate)
|
Zofran
|
8 mg
|
Tablet
|
Serotonin (5HT3) Antagonist
|
Aspen Bad Oldesloe GmbH
|
Germany
|
Automatic Renewal
|
28 September 2022
|
15 October 2027
|
| View |
|
DR-XY13373
|
Sodium Chloride
|
None
|
0.009
|
Solution For Injection (IV/SC)
|
Diluent
|
B. Braun Medical Industries Sdn. Bhd
|
Malaysia
|
Initial (Variation)
|
06 December 2022
|
06 December 2027
|
| View |
|
DR-XY13374
|
Anemizent
|
Iron
|
15 mg (equivalent to 75 mg Ferrous Sulfate
Heptahydrate) / 0.6 mL
|
Syrup (Oral Drops)
|
-
|
San Marino Laboratories, Corporation
|
Philippines
|
-
|
24 November 2021
|
22 January 2025
|
| View |
|
DR-XY13398
|
5% Dextrose in 0.45% Sodium Chloride
|
None
|
Each 100 mL contains: 5g Dextrose Monohydrate & 450mg Sodium Chloride
|
Solution for Intravenous Infusion
|
Electrolyte Replenisher
|
EURO-MED LABORATORIES PHIL., INC.
|
Philippines
|
Automatic Renewal
|
24 December 2021
|
07 March 2027
|
| View |
|
DR-XY13399
|
5% Dextrose In Water Solution For Iv Infusion
|
None
|
Each 100 mL contains 5 g Dextrose Monohydrate
|
Solution For Iv Infusion
|
-
|
EURO-MED LABORATORIES PHIL., INC.
|
Philippines
|
Automatic Renewal
|
29 March 2022
|
01 August 2027
|
| View |
|
DR-XY13460
|
Imipenem + Cilastatin Sodium
|
Tienam
|
500mg
|
Powder for Injection (IV)
|
Antibacterial (Carbapanem)
|
Merck Sharp & Dohme Corp.
|
U.S.A.
|
Automatic Renewal
|
07 December 2021
|
18 January 2027
|
| View |
|
DR-XY13463
|
Nicardipine Hydrochloride
|
Cardepine
|
1 mg/mL (2 mg/2 mL)
|
Solution For Injection (Iv)
|
-
|
Amherst Parenterals, Inc.
|
Philippines
|
-
|
17 January 2020
|
11 February 2025
|
| View |
DR-XY13465_PI_01.pdf
|
DR-XY13465
|
Dexamethasone + Neomycin Sulfate (Equivalent To Neomycin) + Polymyxin B Sulfate
|
Maxitrol
|
1 mg/ 3500 IU/ 6000 IU per mL
|
Sterile Ophthalmic Suspension (Drops)
|
Anti-Inflammatory/Antibacterial
|
Alcon-Couvreur NV
|
Belgium
|
Automatic Renewal
|
23 June 2021
|
27 June 2026
|
| View |
DR-XY13480_PI_01.pdf
|
DR-XY13480
|
Fluorometholone Acetate
|
Flarex
|
(0.1%) 1mg/mL
|
Ophthalmic Suspension
|
Costicosteroids
|
Alcon-Couvreur N.V.
|
Belgium
|
Automatic Renewal
|
27 October 2022
|
05 September 2027
|
| View |
|
DR-XY13538
|
Flouride
|
Infaflor
|
500 mcg/mL
|
Syrup (Oral Drops)
|
-
|
Drugmakers Laboratories, Inc.
|
philipines
|
-
|
25 November 2019
|
26 November 2024
|
| View |
|
DR-XY13568
|
Paracetamol
|
None
|
250mg/ 5mL
|
Syrup
|
Analgesic/Antipyretic
|
Fortis Medi Pharmaceutical, Inc.
|
Philippines
|
Automatic Renewal
|
21 July 2021
|
14 September 2026
|
| View |
|
DR-XY13568-B
|
Paracetamol
|
Medgenol
|
250mg/ 5mL
|
Syrup
|
Analgesic / Antipyretic
|
Fortis Medi Pharmaceutical, Inc.
|
Philippines
|
Automatic Renewal
|
29 September 2021
|
14 September 2026
|
| View |
|
DR-XY13579
|
Salbutamol (as sulfate)
|
Ventolin Nebules
|
1mg/ mL
|
Solution for Inhalation
|
Antiasthma
|
GlaxoSmithKline Australia Pty. Ltd.
|
Australia
|
Automatic Renewal
|
13 January 2022
|
22 December 2026
|
| View |
|
DR-XY13591
|
Proparacaine Hydrochloride
|
Alcaine
|
5mg/mL (0.5%)
|
Sterile Ophthalmic Solution
|
Local Anesthetic
|
Alcon Research, LLC
|
United States of America
|
Initial (Variation)
|
04 October 2022
|
04 October 2027
|
| View |
|
DR-XY13597
|
Nalidixic Acid
|
None
|
500 mg
|
Tablet
|
Antibacterial (Non-Fluorinated Quinolone)
|
Drugmakers Laboratories Inc.
|
Philippines
|
Automatic Renewal
|
05 April 2023
|
04 April 2028
|